GBS Flashcards

1
Q

What are the dominant forms of GBS in Europe and North America?

A

Demyelinating forms with a respiratory prodrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which GBS subtypes are more common in Asia?

A

Axonal subtypes with a preceding diarrheal illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which gender is more commonly affected by Guillain-Barré syndrome?

A

Men are more commonly affected than women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In which age group is the incidence of Guillain-Barré syndrome higher?

A

The incidence is higher in older age groups.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What noninfectious factors are associated with preceding/triggering Guillain-Barré Syndrome?

A

Trauma, surgery, medications (eg ICI).

What about vaccinations?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which pathogens are most consistently associated with GBS?

A

Campylobacter jejuni, hepatitis E virus, cytomegalovirus, Epstein-Barr virus, Mycoplasma pneumoniae, zika virus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the most common infectious trigger for GBS in adults?

A

C. jejuni, present in 30% of all cases. In kids, M. Pneumonia was the most common pathogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What was the severity of GBS presentations for patients with C. jejuni infection?

A

They had the most severe GBS presentations in all geographic areas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the maximum duration of the progressive phase in GBS?

A

Should not progress beyond 4 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are treatment-related fluctuations in GBS?

A

Up to two relapses (worsening GBS disability scale or MRC score) within 8 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What percentage of GBS cases experience treatment-related fluctuations?

A

Up to 10% of cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What condition should be considered in patients with three or more relapses or progression of GBS symptoms beyond 8 weeks?

A

Acute-onset chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common subtype of Guillain-Barré Syndrome in the US and Europe?

A

Acute inflammatory demyelinating polyradiculoneuropathy (AIDP).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the earliest symptoms of Guillain-Barré Syndrome?

A

Distal paresthesia (acroparesthesia) and low back pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which cranial nerve-innervated muscles are affected in GBS?

A

Facial (50%), oropharyngeal (40%), and extraocular (5%-15%) muscles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What percentage of GBS patients require ventilatory support due to respiratory muscle weakness?

A

10% to 30% of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What proportion of patients with GBS experience autonomic abnormalities?

A

About two-thirds of patients have autonomic abnormalities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What autonomic subtype is more common in the acute phase of GBS?

A

Sympathetic activity typically predominates in the acute phase (sinus tachycardia is the most common).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What autonomic subtype is more prominent in the recovery phase of GBS?

A

Parasympathetic failure is more prominent in the recovery phase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some uncommon clinical features in GBS?

A

Papilledema, facial myokymia, hearing loss, meningeal signs, vocal cord paralysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

In what region is AMAN more prevalent?

A

AMAN is more prevalent in Asia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What infectious illness typically precedes AMAN?

A

AMAN is typically preceded by diarrhea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What type of infectious illness typically precedes AMSAN?

A

Respiratory illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is more severe, AMAN or AMSAN?

A

AMSAN is often more severe.

25
Q

Does AMAN or AMSAN typically have more CN and autonomic involvement?

26
Q

What are reflexes like in AMAN?

A

Muscle stretch reflexes might be normal or exaggerated in AMAN.

27
Q

What percentage of patients with Miller Fisher syndrome have GQ1b antibodies?

A

Approximately 85% to 90%.

28
Q

What are the three key clinical features of Miller Fisher syndrome?

A

Ophthalmoplegia, ataxia, and areflexia.

29
Q

What causes ataxia in Miller Fisher syndrome patients?

A

Cerebellar pathology (central) or Ia afferent neuron involvement (peripheral).

30
Q

What symptoms are associated with Bickerstaff brainstem encephalitis?

A

Impaired consciousness (reticular formation), paradoxical hyperreflexia (pyramidal tracts), ataxia, and ophthalmoparesis.

MFS except increased reflexes and impaired consciousness

31
Q

What are the GBS variants?

A
  • Acute bulbar palsy
  • Bilateral Facial Palsy with Paresthesias
  • Pharyngeal-Cervical-Brachial (can look like botulism d/t oropharynx/neck/shoulder involvement)
  • Paraparetic (BLE)
  • Pure sensory Ataxia
  • Acute pandysautonomia
32
Q

What does the pharyngeal-cervical-brachial variant mimic?

33
Q

Which GBS variant mimics an acute spinal cord lesion?

A

Paraparetic variant.

34
Q

What antibody is common in axonal variants of GBS?

A

GM1 antibodies.

35
Q

Which infection often precedes the axonal variants of GBS with GM1 antibodies?

A

C. jejuni infection.

36
Q

GQ1b is strongly expressed in which areas?

A

Extraocular muscles, muscle spindles, and reticular formation.

37
Q

What explains dysphagia in the context of GT1a expression?

A

GT1a expression in the glossopharyngeal and vagal nerves explains dysphagia.

38
Q

What nodal antibodies are involved in AMAN?

A

Presence of IgG anti-GM1 or anti-GD1a autoantibodies.

39
Q

What % of GBS pts have abnormal elevated CSF protein at 1 week? At 2 weeks?

A

At 1 week CSF protein can be normal in up to 50%. At 2 weeks it is increased in > 90%.

40
Q

By when do more than 90% of GBS patients show increased CSF protein levels?

A

By the end of the second week.

41
Q

In GBS, mild CSF pleocytosis (5-10) can be seen in what percentage of patients?

42
Q

What CNS imaging findings are associated with Miller Fisher syndrome?

A

Enhancement of cranial nerves or posterior columns.

43
Q

What does the ‘20/30/40 rule’ assess in GBS patients?

A

Risk for respiratory failure based on vital capacity, inspiratory, and expiratory pressures.

44
Q

What vital capacity measurement indicates risk for respiratory failure in GBS?

A

Vital capacity <20 ml/kg.

45
Q

What maximum inspiratory pressure indicates risk for respiratory failure in GBS?

A

Maximum inspiratory pressure <30 cm H2O.

46
Q

What maximum expiratory pressure indicates a risk for respiratory failure in GBS?

A

<40 cm H2O.

47
Q

What factors prompt ICU admission consideration in GBS patients?

A

Dysautonomia, bulbar dysfunction, severe weakness, evolving respiratory distress.

48
Q

What does an Erasmus GBS Respiratory Insufficiency Score (EGRIS) score of more than 4 indicate?

A

A high (≥65%) risk of respiratory failure.

49
Q

What percentage of GBS patients require mechanical ventilation?

A

Mechanical ventilation is required for 10% to 30% of all patients with GBS.

50
Q

Do IVIg or plasma exchange stop GBS progression?

A

No, they do not stop disease progression or change nerve damage degree.

51
Q

What is less likely in patients with acute-onset CIDP than GBS patients?

A

Autonomic nervous system involvement, facial weakness, preceding infectious illness, or need for ventilation.

52
Q

What does the modified Erasmus GBS Outcome Score predict?

A

Probability of walking independently at 1, 3, and 6 months.

53
Q

When is the modified Erasmus GBS Outcome Score assessed?

A

At hospital admission or 1 week after admission.

54
Q

What factors are used in the modified Erasmus GBS Outcome Score?

A

Age, presence of preceding diarrhea, and the MRC sum score.

55
Q

What percentage of GBS patients can walk independently after 1 yr?

A

Approximately 80% of GBS patients can walk independently and 50% recover fully after 1 yr.

56
Q

How many GBS patients fully recover after 1 year?

A

More than half of GBS patients fully recover after 1 year.

57
Q

What is the overall mortality rate for GBS?

58
Q

What is the mortality rate for ventilator-dependent GBS patients?

A

Around 20%.

59
Q

What are indicators of a higher chance of death in GBS patients?

A

Advanced age, severe disease, ‘associated comorbidities’, pulmonary/cardiac complications, mechanical ventilation, systemic infection.